Existing FDA-approved therapies for nicotine addiction work less than 30% of the time in the long term, and it is common to relapse after quitting, says principal investigator Nicholas Cosford, PhD , deputy director of Sanford Burnham Prebys National Cancer Institute (NCI)-designated Cancer Center and co-founder of Camino Pharma
Dartmouth researchers are also trying to understand other ways in which arsenic increases the risk of certain kinds of cancer
By their estimates, if the current pattern of smoking world-wide doesnt change, 8 million people will die annually from tobacco-related illnesses by the year 2030
A game-changing technology Vapes just like a cigarette is important and a game-changer
The follow-up period was from 1 day after the 2009 NHSP checkup until occurrence of each study outcome (MI, stroke, death), date of death, or December 31, 2018, whichever was the earliest